273 related articles for article (PubMed ID: 27165949)
21. Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses.
Hart RG; Halperin JL; McBride R; Benavente O; Man-Son-Hing M; Kronmal RA
Arch Neurol; 2000 Mar; 57(3):326-32. PubMed ID: 10714657
[TBL] [Abstract][Full Text] [Related]
22. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
[TBL] [Abstract][Full Text] [Related]
23. Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
Uchiyama S; Shinohara Y; Katayama Y; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C
Cerebrovasc Dis; 2014; 37(4):296-303. PubMed ID: 24820203
[TBL] [Abstract][Full Text] [Related]
24. Warfarin and aspirin in patients with heart failure and sinus rhythm.
Homma S; Thompson JL; Pullicino PM; Levin B; Freudenberger RS; Teerlink JR; Ammon SE; Graham S; Sacco RL; Mann DL; Mohr JP; Massie BM; Labovitz AJ; Anker SD; Lok DJ; Ponikowski P; Estol CJ; Lip GY; Di Tullio MR; Sanford AR; Mejia V; Gabriel AP; del Valle ML; Buchsbaum R;
N Engl J Med; 2012 May; 366(20):1859-69. PubMed ID: 22551105
[TBL] [Abstract][Full Text] [Related]
25. Association of aspirin use with major bleeding in patients with and without diabetes.
De Berardis G; Lucisano G; D'Ettorre A; Pellegrini F; Lepore V; Tognoni G; Nicolucci A
JAMA; 2012 Jun; 307(21):2286-94. PubMed ID: 22706834
[TBL] [Abstract][Full Text] [Related]
26. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632
[TBL] [Abstract][Full Text] [Related]
27. Aspirin for primary stroke prevention in elderly patients with vascular risk factors.
Uchiyama S
J Gen Fam Med; 2017 Dec; 18(6):331-335. PubMed ID: 29264061
[TBL] [Abstract][Full Text] [Related]
28. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.
Amarenco P; Davis S; Jones EF; Cohen AA; Heiss WD; Kaste M; Laouénan C; Young D; Macleod M; Donnan GA;
Stroke; 2014 May; 45(5):1248-57. PubMed ID: 24699050
[TBL] [Abstract][Full Text] [Related]
29. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KS;
N Engl J Med; 2016 Jul; 375(1):35-43. PubMed ID: 27160892
[TBL] [Abstract][Full Text] [Related]
30. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
[TBL] [Abstract][Full Text] [Related]
31. Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
Kirshner HS
J Neurol Sci; 2009 Apr; 279(1-2):1-8. PubMed ID: 19185319
[TBL] [Abstract][Full Text] [Related]
32. Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong.
Siu CW; Lip GY; Lam KF; Tse HF
Heart Rhythm; 2014 Aug; 11(8):1401-8. PubMed ID: 24747420
[TBL] [Abstract][Full Text] [Related]
33. Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial.
Cloud GC; Williamson JD; Thao LTP; Tran C; Eaton CB; Wolfe R; Nelson MR; Reid CM; Newman AB; Lockery J; Fitzgerald SM; Murray AM; Shah RC; Woods RL; Donnan GA; McNeil JJ
JAMA Netw Open; 2023 Jul; 6(7):e2325803. PubMed ID: 37494038
[TBL] [Abstract][Full Text] [Related]
34. Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial.
Kim BJ; Kwon SU; Park JH; Kim YJ; Hong KS; Wong LKS; Yu S; Hwang YH; Lee JS; Lee J; Rha JH; Heo SH; Ahn SH; Seo WK; Park JM; Lee JH; Kwon JH; Sohn SI; Jung JM; Navarro JC; Kim HY; Kim EG; Kim S; Cha JK; Park MS; Nam HS; Kang DW;
Stroke; 2020 Mar; 51(3):931-937. PubMed ID: 31856691
[TBL] [Abstract][Full Text] [Related]
35. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
36. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Easton JD; Aunes M; Albers GW; Amarenco P; Bokelund-Singh S; Denison H; Evans SR; Held P; Jahreskog M; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
Circulation; 2017 Sep; 136(10):907-916. PubMed ID: 28655834
[TBL] [Abstract][Full Text] [Related]
37. Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.
Flaker GC; Eikelboom JW; Shestakovska O; Connolly SJ; Kaatz S; Budaj A; Husted S; Yusuf S; Lip GY; Hart RG
Stroke; 2012 Dec; 43(12):3291-7. PubMed ID: 23033347
[TBL] [Abstract][Full Text] [Related]
38. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME;
Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877
[TBL] [Abstract][Full Text] [Related]
39. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation.
Koga M; Yoshimura S; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Todo K; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Yagita Y; Kario K; Shiozawa M; Sato S; Yamagami H; Arihiro S; Toyoda K;
Stroke; 2016 Oct; 47(10):2582-8. PubMed ID: 27531346
[TBL] [Abstract][Full Text] [Related]
40. Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke.
Guo JJ; Xu E; Lin QY; Zeng GL; Xie HF
Neurosci Bull; 2009 Dec; 25(6):383-90. PubMed ID: 19927175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
